Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
Eyre DW. et al, (2021), Clinical Microbiology and Infection, 27, 1516.e7 - 1516.e14
Hepatitis B virus infection as a neglected tropical disease
O’Hara GA. et al, (2017), PLOS Neglected Tropical Diseases, 11, e0005842 - e0005842
1183 IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
Kelly C. et al, (2012), Journal of Hepatology, 56, S468 - S468
65 A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
Kelly C. et al, (2011), Journal of Hepatology, 54, S29 - S29
85 IL28B GENETIC STATUS IN ASSOCIATION WITH HCV SPECIFIC T-CELL IMMUNITY
Bucci C. et al, (2011), Journal of Hepatology, 54, S38 - S38